Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis
Melissa K. Frey, Muhammad Danyal Ahsan, Hannah Bergeron, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 35, pp. 4129-4143
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 91
Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool
Mattia Garutti, Lorenzo Foffano, Roberta Mazzeo, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1025-1025
Open Access | Times Cited: 44
The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer
Anna Öfverholm, Per Karlsson, Anna Rosén
European Journal of Human Genetics (2024) Vol. 32, Iss. 5, pp. 539-544
Open Access | Times Cited: 9
Public perspectives on healthcare professional-directed communication of hereditary genetic risks: a mixed-method systematic review
Lea Godino, Daniela Turchetti, Valentina Gentili, et al.
European Journal of Human Genetics (2025)
Closed Access | Times Cited: 1
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis
Muhammad Danyal Ahsan, Sarah R. Levi, Emily Webster, et al.
PEC Innovation (2023) Vol. 2, pp. 100138-100138
Open Access | Times Cited: 21
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
Shizuko Sei, Aysel Ahadova, Derin B. Keskin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Direct notification by health professionals of relatives at-risk of genetic conditions (with patient consent): views of the Australian public
Jane Tiller, Ami Stott, Keri Finlay, et al.
European Journal of Human Genetics (2023) Vol. 32, Iss. 1, pp. 98-108
Open Access | Times Cited: 16
ACCESS: an empirically-based framework developed by the International Nursing CASCADE Consortium to address genomic disparities through the nursing workforce
Maria C. Katapodi, Carla Pedrazzani, Sivia Barnoy, et al.
Frontiers in Genetics (2024) Vol. 14
Open Access | Times Cited: 6
Patients’ perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure
Charlotta Nääs, Jenny von Salomé, Anna Rosén
European Journal of Human Genetics (2024) Vol. 32, Iss. 4, pp. 448-455
Open Access | Times Cited: 6
Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs
Rachel M. Levine, Ryan Kahn, Luiza Perez, et al.
Familial Cancer (2024) Vol. 23, Iss. 2, pp. 111-120
Closed Access | Times Cited: 6
Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
Jianbang Chiang, Zi Yang Chua, Jia Ying Chan, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation
Fred H. Menko, Sophie L. van der Velden, Diana N. Griffioen, et al.
Journal of Genetic Counseling (2023) Vol. 33, Iss. 3, pp. 615-622
Closed Access | Times Cited: 14
Additional findings from the 100,000 Genomes Project: A qualitative study of recipient perspectives
Joshua Nolan, Jamie I. Forrest, Elizabeth Ormondroyd
Genetics in Medicine (2024) Vol. 26, Iss. 6, pp. 101103-101103
Open Access | Times Cited: 4
National Experiences from 30 Years of Provider-Mediated Cascade Testing in Lynch Syndrome Families—The Danish Model
Lars Joachim Lindberg, Karin Wadt, Christina Therkildsen, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1577-1577
Open Access | Times Cited: 4
Development and implementation of a digiphysical screening model with nationwide reach to diagnose familial hypercholesterolemia
Karin Littmann, Gustav Kindborg, Matthias Lidin, et al.
Digital Health (2025) Vol. 11
Open Access
Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study
Serene Ong, Zi Yang Chua, Jeanette Yuen, et al.
Familial Cancer (2025) Vol. 24, Iss. 1
Closed Access
Public attitudes towards disclosure of genetic risk in the family: a survey in a sample of the Portuguese general population
Iara Pereira Ribeiro, João Tavares, Liliana Sousa, et al.
European Journal of Medical Genetics (2025), pp. 105007-105007
Open Access
Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical Management
T. S. Osler, Mardelle Schoeman, Jenny Edge, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association
Leland E. Hull, Aaron W. Aday, Quan M. Bui, et al.
Circulation (2025)
Closed Access
Developing a questionnaire to explore lay people’s preferences for communicating hereditary conditions within families: insights from a cognitive interview study
Lea Godino, Linda Battistuzzi, Liliana Varesco, et al.
Journal of Community Genetics (2025)
Open Access
Implementation of a Traceback Testing Program for Ovarian Cancer: Findings from the FACTS Study
Nora B. Henrikson, M. Cabell Jonas, Paula R. Blasi, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1154-1154
Open Access
Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis
Emily Webster, Muhammad Danyal Ahsan, Luiza Perez, et al.
JCO Clinical Cancer Informatics (2023), Iss. 7
Open Access | Times Cited: 10
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A
Allison W. Kurian, Isabelle Bedrosian, Wendy Kohlmann, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 4, pp. 466-471
Closed Access | Times Cited: 3
Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management
Eva Ciruelos, José Á. García-Sáenz, Joaquín Gavilá, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1539-1548
Open Access | Times Cited: 3
Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing
Κωνσταντίνος Αγιαννιτόπουλος, Kevisa Potska, Anastasia Katseli, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5218-5218
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top